Renal artery stenosis resident survival guide
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2]
Definition
Renal artery stenosis is defined as a dimished diameter of the lumen of the renal artery. Renal artery of >70% is considered hemodynamically significant.[1]
Causes
Life Threatening Causes
Renal artery stenosis is caused by a heterogenous group of entities, that if left unattended may lead to ischemic nephropathy and consecuently death due to end stage renal disease.
- Atherosclerosis
- Fibromuscular dysplasia
- Neurofibromatosis
- Vasculitis
- Congenital bands
- Radiation
Common Causes
- Atherosclerosis
- Fibromuscular dysplasia
Managment of RAS
Clinical Clues to the Diagnosis of RAS
| Determine if one or more of the following is present: ❑ Onset of hypertension before the age of 30 years or severe hypertension after the age of 55 ❑ Accelerated, resistant, or malignant hypertension ❑ Development of new azotemia or worsening renal function after administration of an ACE inhibitor or ARB agent ❑ Unexplained atrophic kidney or size discrepancy between kidneys >1.5 cm ❑ Sudden, unexplained pulmonary edema ❑ Unexplained renal dysfunction, including individuals starting renal replacement therapy ❑ Multi-vessel CAD ❑ Unexplained CHF ❑ Refractory angina | |||||||||||||||||||||||||||||||||||||||||||
| If yes: ❑ Proceed with non-invasive imaging | If no, but multiple vessel CAD: ❑ Proceed with invasive renal arteriography | ||||||||||||||||||||||||||||||||||||||||||
Is patient allergic to contrast | |||||||||||||||||||||||||||||||||||||||||||
| If yes: ❑ Proceed with US | If no check for: ❑ Implanted devices: - Pacemakers | ❑ Abdominal aortography to assess the renal arteries during coronary and peripheralangiography | |||||||||||||||||||||||||||||||||||||||||
If none of the above proceed with MRA
| If yes to any of the above, proceed with CT | ||||||||||||||||||||||||||||||||||||||||||
Negative noninvasive test but with high clinical suspicion | Evidence of RAS | Evidence of RAS | |||||||||||||||||||||||||||||||||||||||||
Go to invasive imaging | |||||||||||||||||||||||||||||||||||||||||||
Confirmed RAS:
❑Proceed to treatment | |||||||||||||||||||||||||||||||||||||||||||
Algorithm based on the 2013 AHA Guidelines Recommendations for Management of Patients with PAD.[1]
Treatment
| Initiate a regimen that combines: | |||||||||||||||||||||||||||||||||||
| Antihypertensives | Statins | Optimal glycemic control | Smoking cessation counseling | ||||||||||||||||||||||||||||||||
| ❑ Measure creatinine: | |||||||||||||||||||||||||||||||||||
| If >30% rise in serum creatinine: ❑ Stop ACEI and change to another antihypertensive | |||||||||||||||||||||||||||||||||||
| Determine if the following conditions are met: [2] ❑ Hypertension controlled on <3 drugs ❑ Stable mild/moderate renal insufficiency ❑ Advanced renal atrophy (<7.5 cm) ❑ Doppler ultrasonographic renal resistance index >80 (<7.5 cm) ❑ History or clinical evidence of cholesterol embolisation | |||||||||||||||||||||||||||||||||||
| If yes: ❑ Conservative treatment/watchful waiting | If no: ❑ check if any of the following are present | ||||||||||||||||||||||||||||||||||
❑ Hemodynamically significant RAS (see table above) with recurrent, unexplained CHF or sudden, unexplained pulmonary edema ❑ RAS with: - Accelerated, resistant, or malignant hypertension ❑ RAS and CRI with bilateral RAS or RAS to solitary functioning kidney ❑ RAS and unstable angina ❑ Asymptomatic bilateral or solitary viableʰ kidney with a hemodynamically significant RAS ❑ Asymptomatic unilateral hemodynamically significant RAS in a viable kidney (>7cm) ❑ RAS and CRI with unilateral RAS (2 kidneys present) | |||||||||||||||||||||||||||||||||||
| ❑ If answered yes to any: | |||||||||||||||||||||||||||||||||||
| ❑Renal Angioplasty/Stent | ❑ Renal artery surgery | ||||||||||||||||||||||||||||||||||
Atherosclerotic RAS
| Fibromuscular dysplasia RAS
| ||||||||||||||||||||||||||||||||||
| Renal stent placement is indicated for ostial atherosclerotic RAS lesions that meet the clinical criteria for intervention | Balloon angioplasty with bailout stent placement if necessary is recommended for fibromuscular dysplasia lesions | ||||||||||||||||||||||||||||||||||
Algorithm based on the 2013 AHA Guidelines Recommendations for Management of Patients with PAD.[1]
References
- ↑ 1.0 1.1 1.2 Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH; et al. (2013). "Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. 127 (13): 1425–43. doi:10.1161/CIR.0b013e31828b82aa. PMID 23457117.
- ↑ Haller C (2002). "Arteriosclerotic renal artery stenosis: conservative versus interventional management". Heart. 88 (2): 193–7. PMC 1767237. PMID 12117859.